Major discovery! This common drug suppresses new coronavirus

The epidemic of new coronavirus pneumonia has continued to spread. And research on “life-saving drugs” has continued to advance. And major discoveries have been made.

According to the Xinhua News Agency. A joint study by the Shanghai Institute of Materia Medica. And the Wuhan Institute of Virology of the Chinese Academy of Sciences has initially found that Shuanghuanglian Oral Liquid. A proprietary Chinese medicine can inhibit new coronaviruses!

Shuanghuanglian Oral Liquid is an antidote, which has the effects of relieving wind and removing phlegm. Clearing heat and detoxifying. It is used to treat colds caused by wind and heat.

The oral liquid is composed of honeysuckle, Scutellaria baicalensis, and forsythia. And three Chinese medicines. Chinese medicine believes that these three Chinese medicines have the functions of clearing away heat and detoxifying. And superficial and internal clearing.

Modern medical research believes that Shuanghuanglian Oral Liquid has broad-spectrum antiviral, bacteriostatic, and immune-improving functions, and is one of the currently effective broad-spectrum antiviral drugs.

At present, Shuanghuanglian Oral Liquid has been clinically studied in Shanghai Public Health Clinical Center and Tongji Hospital affiliated to Huazhong University of Science and Technology.

It is understood that the Shanghai Institute of Materia Medica has been engaged in antiviral drug research for a long time. During the SARS period in 2003, it was the first to confirm that Shuanghuanglian Oral Liquid has the effect of anti-SARS coronavirus.

Over the past ten years, it has been confirmed that Shuanghuanglian Oral Liquid on H7N9 / H1N1 / H5N1 influenza virus, severe acute respiratory syndrome coronavirus, and Middle East respiratory syndrome coronavirus have significant antiviral effects.

PS: It is just inhibition. This does not mean that drinking Shuanghuanglian oral solution can prevent and cure new coronavirus pneumonia. Do not buy it blindly. Further research is needed.